GN Store Nord | GN - Ebitda

Aktienkurs
94.10
Täglich Wechseln
1.30 1.40%
Monatlich
-9.78%
Jährlich
-0.21%
Q2 Prognose
90.03




Ebitda Veränderung Datum
Demant DKK 2.76B 165M 2025-12
EDAP TMS EUR -4.92M 843K 2025-09
Essilor EUR 3.09B 356M 2024-12
Fresenius EUR 951M 283M 2026-03
Fresenius Medical Care EUR 824M 250M 2026-03
Genmab DKK 186M 291M 2025-12
Getinge SEK 3.47B 2.13B 2024-12
GN Store Nord DKK 491M 136M 2026-03
Lonza CHF 1.01B 54M 2025-12
Pandora DKK 2.15B 2.65B 2026-03
Philips EUR 567M 233M 2026-03
Smith & Nephew USD 796M 139M 2025-12
Trinity Biotech USD -9.6M 7.64M 2024-12